Micro/nanomotors for biofilm remediation: Nanoarchitectonic breakthroughs with a focus on regulatory and clinical translation challenges
Biomaterials · 2026-03 · 326 · 123715
DOI: 10.1016/j.biomaterials.2025.123715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials, 2026-03. Verfasst von Tijana Maric und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechan…. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Nanostructures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, European Research Council, Danmarks Grundforskningsfond.
Abstract (Originalsprache)
Biofilm-associated bacterial infections, notorious for their resistance to standard therapies, pose a critical challenge in clinical practice. Micro and nanomotors (MNMs) have emerged as dynamic tools capable of penetrating biofilm matrices and enabling targeted antimicrobial delivery through autonomous motion. Recent advances in nanoarchitectonic design, spanning fuel-free or chemical propulsion, biohybrid systems, and multimodal actuation, significantly enhance their therapeutic precision and biocompatibility. This review critically examines the evolution of MNM materials, geometries, and designs, emphasizing their mechanical disruption of extracellular polymeric substances and synergistic bactericidal effects. Innovations such as cascade-driven MNMs and stimuli-responsive platforms demonstrate >90 % biofilm eradication in vitro and accelerated wound healing in vivo. What distinguishes this review from existing literature is its integrated focus on regulatory and translational barriers to clinical adoption, an aspect seldom addressed in prior MNM reviews. In addition to advances in materials and design, we discuss challenges that must be overcome for clinical translation, including long-term biosafety, degradation, scalable manufacturing under Good Manufacturing Practice (GMP), and regulatory ambiguities surrounding nanoscale medical devices. We outline a path forward for addressing these barriers by emphasizing the need for standardized toxicity testing, stronger interdisciplinary collaboration, and the use of emerging regulatory tools such as Safe(r) Innovation Approaches (SIA), the EU's Safe and Sustainable by Design (SSbD) initiative, and regulatory sandboxes to help accelerate clinical translation. By integrating material and design innovation with regulatory foresight, MNM technology holds transformative potential for combating antibiotic-resistant infections and redefining the eradication of biofilms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of D…
- Department of Electrical and Photonics Engineering, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
- State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering, Wuhan University of Technology, No.122, Luoshi Road, Wuhan, 430070, China.
- State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, International School of Materials Science and Engineering, Wuhan University of Technology, No.122, Luoshi Road, Wuhan, 430070, China. E…
Förderung
- National Natural Science Foundation of China
- European Research Council
- Danmarks Grundforskningsfond
- Ministry of Science and Technology of the People's Republic of China
- Novo Nordisk Fonden
- Villum Fonden
Zitieren
APA
Maric, T., Tanaka, Y., Li, Z., Wu, J., Li, J., Guan, J., & Boisen, A. (2026). Micro/nanomotors for biofilm remediation: Nanoarchitectonic breakthroughs with a focus on regulatory and clinical translation challenges. Biomaterials, 326, 123715. https://doi.org/10.1016/j.biomaterials.2025.123715
Vancouver
Maric T, Tanaka Y, Li Z, Wu J, Li J, Guan J, et al. Micro/nanomotors for biofilm remediation: Nanoarchitectonic breakthroughs with a focus on regulatory and clinical translation challenges. Biomaterials. 2026;326:123715. doi:10.1016/j.biomaterials.2025.123715
BibTeX
@article{Maric2026,
author = {Maric, Tijana and Tanaka, Yuya and Li, Ziqiao and Wu, Jing and Li, Jialing and Guan, Jianguo and Boisen, Anja},
title = {Micro/nanomotors for biofilm remediation: Nanoarchitectonic breakthroughs with a focus on regulatory and clinical translation challenges},
journal = {Biomaterials},
year = {2026},
volume = {326},
pages = {123715},
doi = {10.1016/j.biomaterials.2025.123715}
}
EUVIMED